Insig AI

By Financial Journalist: Elric Langton | 29 July 2026

Mike and I have a financial interest in INSIG AI.

There comes a point in every investment when patience ceases to be a virtue and begins to resemble excuse-making.

I am increasingly concerned that Insig AI may have reached that point.

We have often made the point here at Lemming Investor that many of the Companies appearing on these pages sit at the riskier end of the market. They are frequently pre-commercial, developing new technologies or attempting to establish products in markets where adoption can take considerably longer than investors initially expect.

They therefore carry substantially more risk than the typical Companies we research for Small Company Champion. We understand that longer timelines demand greater patience, and nobody could reasonably accuse us of failing to afford Insig either.

But patience does not remove the obligation to evaluate the known evidence honestly.

We have given Insig ample coverage and have consistently tried to approach the Company with balance, allowing management the time and space needed to demonstrate commercial progress. More recently, however, we were told that elements of our analysis were wrong. No substantive counterargument was provided, nor were we shown which conclusions were supposedly incorrect or what evidence contradicted them.

Instead, the response included an alternative AI-generated assessment that appeared considerably more sympathetic to the Company’s position.

That did little to change our view. If anything, it reinforced the concern that CEO Richard Bernstein’s criticism was more defensive than analytical. Investors cannot be expected to abandon a reasoned interpretation of the available data merely because the chairman dislikes the conclusion.

We remain open to being proved wrong. But that requires evidence, not irritation.